Fine‐needle aspiration cytology for parotid lesions, can we avoid surgery?

Fine‐needle aspiration cytology for parotid lesions, can we avoid surgery? KeypointsIn patients undergoing parotidectomy, 20% have a malignant pathology.Overall accuracy of FNAC for benign etiologies was 82.6%.PPV for benign etiologies mostly ranges between 80 to 90%, with some subpopulations having higher values.In the 26% of cases were a malignant pathology was encountered, the FNAC was either benign or undiagnostic.FNAC results should be taken cautiously and always in context of the patient's history and physical examination.INTRODUCTIONSalivary gland neoplasms account for only 3% of all tumours; most (80%) arise in the parotid gland. The reported malignancy rate of parotid gland neoplasms ranges from 13% to 32%. The two most common benign parotid lesions are pleomorphic adenoma and Warthin tumour. The two most common malignancies are metastatic squamous cell carcinoma and mucoepidermoid carcinoma. Patient age at diagnosis is about 60 years for malignant parotid tumours and lower for benign tumours.Traditionally, parotid neoplasms are evaluated by fine‐needle aspiration cytology (FNAC). However, although FNAC has been found to be highly accurate for the diagnosis of neoplasm in other sites of the head and neck (eg thyroid, lymph nodes), its benefit in the parotid is controversial due to lower accuracy, mainly due to the many different pathologies encountered in the parotid gland. Earlier studies of http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Otolaryngology Wiley

Fine‐needle aspiration cytology for parotid lesions, can we avoid surgery?

Loading next page...
 
/lp/wiley/fine-needle-aspiration-cytology-for-parotid-lesions-can-we-avoid-sLAMNI7ZQx
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 John Wiley & Sons Ltd
ISSN
1749-4478
eISSN
1749-4486
D.O.I.
10.1111/coa.13038
Publisher site
See Article on Publisher Site

Abstract

KeypointsIn patients undergoing parotidectomy, 20% have a malignant pathology.Overall accuracy of FNAC for benign etiologies was 82.6%.PPV for benign etiologies mostly ranges between 80 to 90%, with some subpopulations having higher values.In the 26% of cases were a malignant pathology was encountered, the FNAC was either benign or undiagnostic.FNAC results should be taken cautiously and always in context of the patient's history and physical examination.INTRODUCTIONSalivary gland neoplasms account for only 3% of all tumours; most (80%) arise in the parotid gland. The reported malignancy rate of parotid gland neoplasms ranges from 13% to 32%. The two most common benign parotid lesions are pleomorphic adenoma and Warthin tumour. The two most common malignancies are metastatic squamous cell carcinoma and mucoepidermoid carcinoma. Patient age at diagnosis is about 60 years for malignant parotid tumours and lower for benign tumours.Traditionally, parotid neoplasms are evaluated by fine‐needle aspiration cytology (FNAC). However, although FNAC has been found to be highly accurate for the diagnosis of neoplasm in other sites of the head and neck (eg thyroid, lymph nodes), its benefit in the parotid is controversial due to lower accuracy, mainly due to the many different pathologies encountered in the parotid gland. Earlier studies of

Journal

Clinical OtolaryngologyWiley

Published: Jan 1, 2018

Keywords: ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial